pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine

C137H128N34O9 — CID 157061203

IUPACpentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine
SMILESCOc1ccc(-c2cnc3cn[nH]c3c2)cc1.COc1ccc2cc(-c3cnc4cn[nH]c4c3)ccc2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.Cc1cccc(-c2cnc3cn[nH]c3c2)c1.Cc1cnc2ccc(O)cn12.Cn1cc(-c2cnc3cn[nH]c3c2)cn1.c1cc(N2CCOCC2)ccc1-c1cnc2cn[nH]c2c1.c1ccc2c(-c3cnc4cn[nH]c4c3)cncc2c1
InChIInChI=1S/C17H13N3O.C16H16N4O.C15H10N4.C13H11N3O.C13H11N3.C10H9N5.5C9H10N2O.C8H8N2O/c1-21-15-5-4-11-6-12(2-3-13(11)7-15)14-8-16-17(18-9-14)10-19-20-16;1-3-14(20-5-7-21-8-6-20)4-2-12(1)13-9-15-16(17-10-13)11-18-19-15;1-2-4-12-10(3-1)6-16-8-13(12)11-5-14-15(17-7-11)9-18-19-14;1-17-11-4-2-9(3-5-11)10-6-12-13(14-7-10)8-15-16-12;1-9-3-2-4-10(5-9)11-6-12-13(14-7-11)8-15-16-12;1-15-6-8(4-13-15)7-2-9-10(11-3-7)5-12-14-9;5*1-7-5-10-9-4-3-8(12-2)6-11(7)9;1-6-4-9-8-3-2-7(11)5-10(6)8/h2-10H,1H3,(H,19,20);1-4,9-11H,5-8H2,(H,18,19);1-9H,(H,18,19);2-8H,1H3,(H,15,16);2-8H,1H3,(H,15,16);2-6H,1H3,(H,12,14);5*3-6H,1-2H3;2-5,11H,1H3
InChIKeyABIUTOWFKZBMIJ-UHFFFAOYSA-N
MW2394.76 g/mol
LogP25.95
Rot. Bonds14

About pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine

pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine (PubChem CID 157061203) has the molecular formula C137H128N34O9 and a molecular weight of 2394.76 g/mol. Its IUPAC name is pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine.

Molecular Properties

Compound Namepentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine
PubChem CID157061203
Molecular FormulaC137H128N34O9
Molecular Weight2394.76 g/mol
Exact Mass2393.06
IUPAC Namepentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine
SMILESCOc1ccc(-c2cnc3cn[nH]c3c2)cc1.COc1ccc2cc(-c3cnc4cn[nH]c4c3)ccc2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.Cc1cccc(-c2cnc3cn[nH]c3c2)c1.Cc1cnc2ccc(O)cn12.Cn1cc(-c2cnc3cn[nH]c3c2)cn1.c1cc(N2CCOCC2)ccc1-c1cnc2cn[nH]c2c1.c1ccc2c(-c3cnc4cn[nH]c4c3)cncc2c1
InChIInChI=1S/C17H13N3O.C16H16N4O.C15H10N4.C13H11N3O.C13H11N3.C10H9N5.5C9H10N2O.C8H8N2O/c1-21-15-5-4-11-6-12(2-3-13(11)7-15)14-8-16-17(18-9-14)10-19-20-16;1-3-14(20-5-7-21-8-6-20)4-2-12(1)13-9-15-16(17-10-13)11-18-19-15;1-2-4-12-10(3-1)6-16-8-13(12)11-5-14-15(17-7-11)9-18-19-14;1-17-11-4-2-9(3-5-11)10-6-12-13(14-7-10)8-15-16-12;1-9-3-2-4-10(5-9)11-6-12-13(14-7-11)8-15-16-12;1-15-6-8(4-13-15)7-2-9-10(11-3-7)5-12-14-9;5*1-7-5-10-9-4-3-8(12-2)6-11(7)9;1-6-4-9-8-3-2-7(11)5-10(6)8/h2-10H,1H3,(H,19,20);1-4,9-11H,5-8H2,(H,18,19);1-9H,(H,18,19);2-8H,1H3,(H,15,16);2-8H,1H3,(H,15,16);2-6H,1H3,(H,12,14);5*3-6H,1-2H3;2-5,11H,1H3
InChIKeyABIUTOWFKZBMIJ-UHFFFAOYSA-N
XLogP25.95
TPSA481.24 Ų
H-Bond Donors7
H-Bond Acceptors37
Rotatable Bonds14
Heavy Atoms180
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002394.76
LogP ≤ 525.95
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1037

Analyze pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[(6-methoxyimidazo[1,2-a]pyridin-3-yl)methyl]-6-(1-methylpyrazol-4-yl)pyrazolo[4,5-b]pyridine
CID 121339284
4-(4-methoxyphenyl)-1-methylpyrazole
CID 4101323
5-(4-methoxyphenyl)-N-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,5-d]pyrimidin-7-amine
CID 71138008
1-[4-[4-(1-methylpyrazol-4-yl)phenyl]isoquinolin-6-yl]pyrrolidin-3-one
CID 118660770
3-(4-morpholin-4-ylphenyl)phenol
CID 46887508
7-fluoro-6-[1-(6-isoquinolin-4-yl-2H-triazolo[4,5-b]pyrazin-5-yl)ethyl]-3-(1-methylpyrazol-4-yl)quinoline
CID 141456395
9-[3,5-bis(3-methylphenyl)phenyl]-10-phenylanthracene;9,10-dinaphthalen-1-ylanthracene;9-(3,5-dinaphthalen-1-ylphenyl)-10-(6-phenylnaphthalen-2-yl)anthracene;9-(6-methoxynaphthalen-2-yl)-10-(6-methylnaphthalen-2-yl)anthracene;9-naphthalen-1-yl-10-phenylanthracene
CID 159430321
4-(7-methyl-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)morpholine
CID 91197885
1-[4-(1-methylpyrazol-4-yl)naphthalen-2-yl]oxy-3-[4-(1H-1,2,4-triazol-5-yl)piperazin-1-yl]propan-2-ol
CID 176503769
3-methyl-6-(1-methylpyrazol-4-yl)isoquinolin-4-ol
CID 168925716
2-[3-(1-methylpyrazol-4-yl)phenoxy]-1-morpholin-4-ylethanone
CID 91027875
7-(3-methoxyphenyl)-N-(4-morpholin-4-ylphenyl)-1,3-benzoxazol-2-amine
CID 24801484

Frequently Asked Questions

What is the IUPAC name of pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine?
The IUPAC name of pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine (CID 157061203) is pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine.
What is the SMILES notation for pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine?
The canonical SMILES for pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine is COc1ccc(-c2cnc3cn[nH]c3c2)cc1.COc1ccc2cc(-c3cnc4cn[nH]c4c3)ccc2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.COc1ccc2ncc(C)n2c1.Cc1cccc(-c2cnc3cn[nH]c3c2)c1.Cc1cnc2ccc(O)cn12.Cn1cc(-c2cnc3cn[nH]c3c2)cn1.c1cc(N2CCOCC2)ccc1-c1cnc2cn[nH]c2c1.c1ccc2c(-c3cnc4cn[nH]c4c3)cncc2c1.
What is the InChIKey of pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine?
The InChIKey is ABIUTOWFKZBMIJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H13N3O.C16H16N4O.C15H10N4.C13H11N3O.C13H11N3.C10H9N5.5C9H10N2O.C8H8N2O/c1-21-15-5-4-11-6-12(2-3-13(11)7-15)14-8-16-17(18-9-14)10-19-20-16;1-3-14(20-5-7-21-8-6-20)4-2-12(1)13-9-15-16(17-10-13)11-18-19-15;1-2-4-12-10(3-1)6-16-8-13(12)11-5-14-15(17-7-11)9-18-19-14;1-17-11-4-2-9(3-5-11)10-6-12-13(14-7-10)8-15-16-12;1-9-3-2-4-10(5-9)11-6-12-13(14-7-11)8-15-16-12;1-15-6-8(4-13-15)7-2-9-10(11-3-7)5-12-14-9;5*1-7-5-10-9-4-3-8(12-2)6-11(7)9;1-6-4-9-8-3-2-7(11)5-10(6)8/h2-10H,1H3,(H,19,20);1-4,9-11H,5-8H2,(H,18,19);1-9H,(H,18,19);2-8H,1H3,(H,15,16);2-8H,1H3,(H,15,16);2-6H,1H3,(H,12,14);5*3-6H,1-2H3;2-5,11H,1H3.
What are the key properties of pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine?
pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine has a molecular weight of 2394.76 g/mol, XLogP of 25.95, 14 rotatable bonds, 7 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for pentakis(6-methoxy-3-methylimidazo[1,2-a]pyridine);6-(6-methoxynaphthalen-2-yl)-1H-pyrazolo[4,5-b]pyridine;6-(4-methoxyphenyl)-1H-pyrazolo[4,5-b]pyridine;3-methylimidazo[1,2-a]pyridin-6-ol;6-(3-methylphenyl)-1H-pyrazolo[4,5-b]pyridine;6-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,5-b]pyridine;4-(1H-pyrazolo[4,5-b]pyridin-6-yl)isoquinoline;4-[4-(1H-pyrazolo[4,5-b]pyridin-6-yl)phenyl]morpholine is sourced from PubChem (CID 157061203), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).